Janus Henderson Group
TXG icon

Janus Henderson Group’s 10x Genomics TXG Stock Holding History

Janus Henderson Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.48M Sell
305,268
-240,558
-44% -$4.81M ﹤0.01% 883
2025
Q4 		$8.9M Sell
545,826
-387,096
-41% -$5.85M ﹤0.01% 770
2025
Q3 		$10.9M Buy
932,922
+883,234
+1,778% +$11.5M 0.01% 727
2025
Q2 		$575K Hold
49,688
– – ﹤0.01% 1876
2025
Q1 		$455K Hold
49,688
– – ﹤0.01% 2006
2024
Q4 		$714K Hold
49,688
– – ﹤0.01% 1856
2024
Q3 		$1.12M Hold
49,688
– – ﹤0.01% 1605
2024
Q2 		$965K Buy
49,688
+10,888
+28% +$285K ﹤0.01% 1637
2024
Q1 		$1.46M Hold
38,800
– – ﹤0.01% 1438
2023
Q4 		$2.17M Sell
38,800
-23
-0.1% -$1K ﹤0.01% 1213
2023
Q3 		$1.6M Buy
38,823
+12
+0% +$624 ﹤0.01% 1302
2023
Q2 		$2.17M Sell
38,811
-49
-0.1% -$2.65K ﹤0.01% 1201
2023
Q1 		$2.17M Buy
38,860
+23,881
+159% +$1.12M ﹤0.01% 1210
2022
Q4 		$546K Hold
14,979
– – ﹤0.01% 1661
2022
Q3 		$427K Sell
14,979
-1,900
-11% -$72.4K ﹤0.01% 1653
2022
Q2 		$764K Sell
16,879
-39,232
-70% -$2.04M ﹤0.01% 1492
2022
Q1 		$4.27M Sell
56,111
-201,499
-78% -$17.6M ﹤0.01% 1045
2021
Q4 		$38.4M Buy
257,610
+222,183
+627% +$34M 0.02% 627
2021
Q3 		$5.16M Buy
35,427
+31,529
+809% +$5.41M ﹤0.01% 1044
2021
Q2 		$764K Buy
+3,898
New +$705K ﹤0.01% 1363
2021
Q1 		– Sell
-36,192
Closed -$5.13M – 1629
2020
Q4 		$5.13M Buy
+36,192
New +$5.25M ﹤0.01% 956
2019
Q4 		– Sell
-28,481
Closed -$1.44M – 1465
2019
Q3 		$1.44M Buy
+28,481
New +$1.58M ﹤0.01% 1189

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group's TXG Position: Q1 2026 in Review

Janus Henderson Group reduced its 10x Genomics (TXG) stake by 44% in Q1 2026, selling an estimated $4.81M and leaving 305,268 shares worth $6.48M. The position accounts for ﹤0.01% of the portfolio, ranked #883.

Janus Henderson Group first reported a position in TXG in Q3 2019 and has held it in 22 quarters since. The position peaked at $38.4M in Q4 2021. 331 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Janus Henderson Group held 305,268 shares of 10x Genomics worth $6.48M as of Q1 2026.
  • Janus Henderson Group sold 240,558 10x Genomics shares in Q1 2026, an estimated $4.81M.
  • 10x Genomics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #883 holding.
  • Janus Henderson Group first reported a position in 10x Genomics in Q3 2019 and has held it in 22 quarters since.
  • Janus Henderson Group's 10x Genomics position peaked at $38.4M in Q4 2021.
  • 331 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.